FDA approves GW Pharmaceuticals’ CBD drug for new indication
CBD drug Epidiolex received approval from the U.S. Food and Drug Administration to treat seizures associated with a third medical condition, expanding the range of indications for the cannabis-derived medication. The orally administered drug from Britain’s GW Pharmaceuticals previously was approved by the FDA to treat seizures associated with... Read more
Chart: 2020 an ‘extinction event’ for thousands of CBD companies, but industry remains crowded
Rocked by a global pandemic and its resulting economic havoc, thousands of CBD companies in the United States will likely shutter in 2020 – but the CBD market will remain flooded with some 1,500 brands jostling for market share, according to cannabis research firm Brightfield Group. The top 20... Read more
Fees changing for foreign temporary labor visas
Hemp businesses using temporary foreign workers are going to see changing fee schedules for visas starting this fall. The U.S. Department of Homeland Security published a series of fee changes for visas on Monday. Visa programs are funded by user fees, which must be updated to cover costs. The... Read more
House Approves Appropriations Amendment to Protect State-Legal Cannabis Markets
Provision would prevent federal interference in all legal cannabis programs, including adult use After approving legislation to protect state cannabis programs in a voice vote on Thursday afternoon, the House of Representatives reiterated its support with a roll call vote of 254-163 hours later. The bipartisan amendment to the... Read more
‘If you listen to the consumer, you’re going to be right’: Q&A with Neptune Wellness CEO Michael Cammarata
(This is an abridged version of a feature that appears in the July issue of Marijuana Business Magazine.) How did a dyslexic 13-year-old who learned how to program computers, manage a mainstream pop band and build and sell a national deodorant brand come to lead a cannabis business? Michael... Read more
FDA reissues post on recall of lead-contaminated CBD oil from Florida manufacturer
The U.S. Food and Drug Administration has updated a post on its website to spread the word about a Florida company that recalled a batch of CBD oil after a state agency tested the product and found that it contained dangerous levels of lead. Summitt Labs is voluntarily recalling... Read more
Switzerland refunds $36M in taxes levied on low-THC cannabis growers, sellers
Swiss customs officials have returned approximately CHF 33 million ($36 million) to low-THC cannabis flower producers and sellers after a court said their products were unconstitutionally taxed as a tobacco substitute. CBD sellers in Switzerland had taken legal action to protest the 25% sales tax imposed on their goods... Read more
Action Alert: Protect State Cannabis Programs
In the coming days, the House of Representatives will vote on protecting adult-use cannabis businesses, consumers, and state programs from the federal government and we need your help now. The Blumenauer-Norton-Lee-McClintock amendment states that no funds from the Department of Justice may be used to prevent any adult-use cannabis states... Read more
SEC complaint: 400 investors defrauded of $25M for supposed marijuana farm, CBD extraction facility
The U.S. Securities and Exchange Commission is accusing six individuals of fraudulently raising $25 million from 400 investors for a part in a supposed marijuana farm and CBD extraction facility. The money was raised from people across the country between September 2017 and February 2019, according to the complaint... Read more
EU Commission revises stance on WHO cannabis scheduling vote as it leans toward CBD as a narcotic
The executive branch of the European Union is changing its stance on how EU countries should vote on the World Health Organization’s cannabis scheduling changes in December, Hemp Industry Daily has learned. The development comes on the heels of the European Commission announcing its preliminary view that CBD extracted... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )